Raíces M

Language: English
References: 9
Page: 38-40
PDF size: 80.36 Kb.

ABSTRACT

Last February 9-10^th, the Philippine Wound Care Society, celebrated its first annual convention entitled “Revisiting Wound Care: Principles and Management in the Clinical Setting”, at Manila, Philippines. Several experts from different specialties and countries discussed about basic pathophysiology of wounds, their diagnosis and assessment, compression therapies, role of different medical and surgical subspecialties including ancillary services, wound care by nurse and dieticians, chronic leg wound due to peripheral arterial disease, venous stasis ulcers, lymphedema, decubitus ulcers and, finally, diabetes foot ulcers (DFUs). In parallel to the Wound convention, a set of Workshop/Demo classes were held on the 2nd day by companies specializing in wound care products. On February 10th, the company Chemway Pharma, in coordination with the Center for Genetic Engineering and Biotechnology (CIGB) of Havana, Cuba, organized a Product Launch symposium, where two experts from Cuba and one from Philippines talked about Heberprot-P, a novel Cuban product to induce fast and high quality healing of DFUs. This symposium was entitled “Intralesional Human Recombinant Epidermal Growth Factor (Heberprot-P) for the treatment of advanced diabetic foot ulcers” and consisted on three lectures, two of them given by the Cuban specialists Dr. Manuel Raíces and Dr. Arístides l. García, who respectively brought details on the genesis of Heberprot-P and its healing results in DFU patients. The symposium was closed with the lecture of Dr. Rainan Gloria from Philippines, who showed the positive evolution of three Philippine DFU patients under Heberprot-P therapy.

REFERENCES

1. Nguyen DT, Orgill DP, Murphy GF. Chapter 4: The Pathophysiologic Basis for Wound Healing and Cutaneous Regeneration. In: Orgill D, Blanco C, editors. Biomaterials for Treating Skin Loss. Cambridge/Boca Raton: Woodhead Publishing (UK/Europe) & CRC Press (US); 2009. p. 25-57.

2. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 1998;176(2A Suppl):26S-38S.

3. Garg HG, Longaker MT, editors. Scarless Wound Healing. New York: Marcel Dekker, Inc; 2000.

4. Enoch S, Price P. Cellular, molecular and biochemical differences in the pathophysiology of healing between acute wounds, chronic wounds and wounds in the aged [Internet]. Bridgend: World Wide Wounds; 2004 [cited 2012 Mar 12]. Available from: www.worldwidewounds.com/2004/august/Enoch/Pathophysiology-Of-Healing.html.

5. International Diabetes Federation. IDF Diabetes Atlas. 5th edition. Brussels(Belgium): International Diabetes Federation; 2011.

6. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetic Care. 1983;6:87-91.

7. The Philippine Wound Care Society [Internet]. Manila: The Society. 2009 [cited 2012 Mar 12]. Available from: www.philippinewoundcaresociety.org.

8. 1st Annual Convention of the PWCS “Revisiting Wound Care: Principles and Management in the Clinical Setting” [Internet]. Manila: The Philippine Wound Care Society. 2012 [cited 2012 Mar 12] Available from: http://www.philippinewoundcaresociety.org/p/annual-convention.html.

9. 4th Congress of the World Union of Wound Healing Societies, WUWHS 2012 [Internet]. Tokio: The Union. c2012 [updated 2012 Mar 21; cited 2012 Mar 26]. Available from: http://wuwhs2012.com.